LIVIXIL PAK- lidocaine 2.5% and prilocaine 2.5% kit

Država: Združene države Amerike

Jezik: angleščina

Source: NLM (National Library of Medicine)

Aktivna sestavina:

PRILOCAINE (UNII: 046O35D44R) (PRILOCAINE - UNII:046O35D44R), LIDOCAINE (UNII: 98PI200987) (LIDOCAINE - UNII:98PI200987)

Dostopno od:

Alvix Laboratories, LLC

INN (mednarodno ime):

PRILOCAINE

Sestava:

PRILOCAINE 25 mg in 1 g

Pot uporabe:

TOPICAL

Tip zastaranja:

PRESCRIPTION DRUG

Terapevtske indikacije:

Lidocaine and prilocaine cream (a eutectic mixture of lidocaine 2.5% and prilocaine 2.5%) is indicated as a topical anesthetic for use on: - normal intact skin for local analgesia. - genital mucous membranes for superficial minor surgery and as pretreatment for infiltration anesthesia. Lidocaine and prilocaine cream is not recommended in any clinical situation when penetration or migration beyond the tympanic membrane into the middle ear is possible because of the ototoxic effects observed in animal studies (see WARNINGS). Lidocaine and prilocaine cream (lidocaine 2.5% and prilocaine 2.5%) is contraindicated in patients with a known history of sensitivity to local anesthetics of the amide type or to any other component of the product.

Povzetek izdelek:

LIVIXIL Pak (Lidocaine 2.5% and Prilocaine 2.5% Cream, USP) with Occlusive Dressing Contains: NOT FOR OPHTHALMIC USE. KEEP CONTAINER TIGHTLY CLOSED AT ALL TIMES WHEN NOT IN USE. Storage: Store at 20º to 25ºC (68º to 77ºF) [see USP Controlled Room Temperature]. Rx only Keep out of the reach of children. Manufactured By: IGI Laboratories Inc. Buena, NJ 08310 USA OR Fougera Pharmaceuticals, Inc. Melville, NY 11747 Packaged By: Alvix Laboratories, LLC 6601 Sunplex Drive Ocean springs, MS 39564 1-888-526-5449 www.alvix.com

Status dovoljenje:

unapproved drug other

Lastnosti izdelka

LIVIXIL PAK- LIDOCAINE 2.5% AND PRILOCAINE 2.5%
ALVIX LABORATORIES, LLC
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this labeling has not been_
_approved by FDA. For further information about unapproved drugs,
click here._
----------
LIVIXIL PAK (LIDOCAINE 2.5% AND PRILOCAINE 2.5% CREAM, USP)
DESCRIPTION
Lidocaine 2.5% and Prilocaine 2.5% Cream, USP is an emulsion in which
the oil phase is a eutectic
mixture of lidocaine and prilocaine cream in a ratio of 1:1 by weight.
This eutectic mixture has a
melting point below room temperature and therefore both local
anesthetics exist as a liquid oil rather
than as crystals. It is packaged in 5 gram and 30 gram tubes.
Lidocaine is chemically designated as acetamide,
2-(diethylamino)-N-(2,6-dimethylphenyl), has an
octanol: water partition ratio of 43 at pH 7.4, and has the following
structure:
Prilocaine is chemically designated as propanamide,
N-(2-methylphenyl)-2-(propylamino), has an
octanol: water partition ratio of 25 at pH 7.4, and has the following
structure:
Each gram of lidocaine and prilocaine cream contains lidocaine 25 mg,
prilocaine 25 mg,
polyoxyethylene fatty acid esters (as emulsifiers),
carboxypolymethylene (as a thickening agent),
sodium hydroxide to adjust to a pH approximating 9, and purified water
to 1 gram. Lidocaine and
prilocaine cream contains no preservative, however it passes the USP
antimicrobial effectiveness test
due to the pH. The specific gravity of lidocaine and prilocaine cream
is 1.00.
CLINICAL PHARMACOLOGY
MECHANISM OF ACTION: Lidocaine and prilocaine cream applied to intact
skin under occlusive dressing,
provides dermal analgesia by the release of lidocaine and prilocaine
from the cream into the epidermal
and dermal layers of the skin and by the accumulation of lidocaine and
prilocaine in the vicinity of
dermal pain receptors and nerve endings. Lidocaine and prilocaine are
amide-type local anesthetic
agents. Both lidocaine and prilocaine stabilize neuronal membranes by
inhibiting the ionic fluxes
requi